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Summary
SUMMARY
The relaxin (RLN) peptides exert different biological effects ranging
from reproduction to regulating central nervous processes. Until now,
few studies have been performed in embryonic development and in
vertebrate models beyond mammals. I used zebrafish, as experimental
model, to characterize the spatial and temporal expression pattern of
the relaxin/receptor system in vertebrate embryogenesis. In previous
analysis,  the  expression  pattern  of  the  zebrafish  rln3a  and  rln3b
paralogue  genes  was  characterized.  These  paralogue  genes  are
expressed  in  periaqueductal  gray  and  nucleus  incertus,  showing  a
conserved  expression  pattern  during  vertebrate  evolution.  In  this
thesis,  I  demonstrated  that  another  member  of  zebrafish  relaxin
family, the rln, is express in many brain areas of zebrafish embryo. In
particular, I showed that the  rln  transcript co-localized with  rln3a  in
the putative nucleus incertus (NI).  The  rln  gene expression in many
developing  brain  regions  is  in  line  with  the  phylogenetic  analysis,
which  suggests  that  teleost  rln gene  is  closely related  to  rln3-like
ancestor gene.  The  insl-5a and  insl-5b paralogue genes showed their
expression  localized  in  two  distinct  cellular  types  of  intestinal
epithelium.  My  data  showed  that  the  insl5 expression  pattern  is
conserved  from fish  to  mammals,  since  the  human INSL5  gene  is
expressed in the intestinal tissue; in addition, they showed that a sub-
functionalization  event  likely  differentiated  the  gene  expression
regulation of the two zebrafish paralogue genes. Beyond the ligands, I
extend the gene expression characterization to the relaxins receptors
encoding genes. I demonstrated that the zebrafish rxfp1 gene has the
same  syntenic  genomic  organization,  and  a  similar  exon-intron
structure  to  the  human homologue  gene.  Furthermore,  the  deduced
Rxfp1 protein sequence shows a high degree of amino acid similarity
when compared with the human protein and the conservation of all
amino acid identity necessary for the binding with relaxin. The rxfp1
expression  pattern  in  Danio  rerio embryos  is  very  similar  to  that
reported in the adult mammalian brain, suggesting a pivotal role of
this receptor in the neurophysiology processes already at very early
developmental  stages.  Only  one  of  three  rxfp2 paralogue  gene  is
expressed during embryonic developmental stage and its transcript is
localized in pineal gland, habenula and preoptic area. The analysis of
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rxfp3  paralogue  genes  expression  pattern  showed  that  they  are
differentially  expressed  both  in  neural  tissues  and  non-neural
territories.  I  showed  that,  in  embryonic  development,  the  different
expression areas of relaxin receptors and probably their function are
conserved between mammals and fishes. Overall,  my data provided
evidence  that  the  relaxin/receptor  system is  active during zebrafish
embryogenesis, and that their expression territories and probably their
function are conserved between mammals and fishes. 
III
Riassunto
RIASSUNTO
Le relassine  sono  ormoni  peptidici  che  esercitano  svariati  effetti
biologici  sulla  riproduzione  e  sui  processi  neurali.  Lo  studio  della
famiglia  delle  relassine  e  dei  rispettivi  recettori  si  è  incentrato
principalmente su organismi adulti e su modelli sperimentali  di specie
mammifere. Al contrario, pochi dati sono disponibili sul ruolo svolto
durante l’embriogenesi ed in organismi diversi dai mammiferi. Per il
mio progetto di dottorato, ho usato come modello sperimentale Danio
rerio,  comunemente  noto  come pesce  zebra,  al  fine  di  allargare  la
conoscenza sul sistema relassina/recettore durante l’embriogenesi dei
vertebrati. 
Analisi  precedenti  effettuate  nel  laboratorio  dove  ho  svolto  il  mio
lavoro  di  ricerca,  hanno  dimostrato  che,  durante  lo  sviluppo
embrionale, i geni paraloghi di uno dei membri della famiglia delle
relassine,  rln3a e rln3b,  sono  entrambi  espressi  nel  cervello  di
zebrafish, in una regione omologa al nucleo incerto dei mammiferi.
Nel mio lavoro di tesi, ho ampliato l’analisi agli altri membri della
famiglia delle relassine ed ai rispettivi recettori. La caratterizzazione
del gene  rln ha mostrato che,  la  sequenza  amminoacidica possiede
un'elevata percentuale d'identità con i due paraloghi rln3a e rln3b del
pesce zebra, avvalorando l'ipotesi che l'intera famiglia delle relassine
si sia evoluta da un unico gene ancestrale  rln3-simile. Il  gene  rln è
espresso nel sistema nervoso centrale ed il suo trascritto co-localizza
con il gene rln3a nel putativo nucleo incerto. Nell'insieme i territori di
espressione del gene rln nel pesce zebra, comparati a quelli del ratto,
fanno  ipotizzare  un  ruolo  nei  processi  neuroendocrini  e  sensoriali,
conservato  nell'evoluzione  dei  vertebrati.  Inoltre,  la  presenza  del
trascritto a livello della regione pancreatica e della tiroide, fa supporre
una funzione di Rln come ormone endocrino e paracrino. I territori di
espressione dei due paraloghi insl5a e insl5b sono anch'essi conservati
durante l’evoluzione, essendo entrambi espressi a livello dell’intestino
come per i mammiferi. Inoltre, data la loro espressione in tipi cellulari
differenti,  si  è ipotizzato un processo di  sub-funzionalizzazione dei
due  geni  paraloghi.  Le  relassine  interagiscono  con  una  classe  di
recettori accoppiati a proteine G (GPCR), noti come RXFP. In seconda
analisi, la mia attività di ricerca si è focalizzata sulla caratterizzazione
dei profili di espressione genica di tali recettori. L’omologo nel pesce
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zebra del recettore RXFP1 mostra un elevato livello di conservazione
sia nella struttura del gene che nella sequenza amminoacidica. Anche i
territori  di  espressione  risultano  conservati  nell'evoluzione  dei
vertebrati,  suggerendo  un  ruolo  centrale  di  questo  recettore  nei
processi neurali già nelle prime fasi di vita di un organismo. RXFP2
presenta  3  omologhi  nel  pesce  zebra,  ma  solo  uno  di  essi  risulta
espresso durante lo sviluppo embrionale, a partire dallo stadio larvale.
L'espressione genica è stata rivelata in territori come l'epifisi, l'abenula
e l'area preottica, strutture correlate al controllo degli stati emotivi ed
al ritmo circadiano. RXFP3 e RXFP4 sono i recettori che presentano
una situazione più complessa nel pesce zebra, infatti nel suo genoma
sono presenti 7 geni omologhi, di cui solo alcuni di essi sono espressi
durante  lo  sviluppo  embrionale.  L'analisi  di  localizzazione  dei
rispettivi mRNA, ha mostrato che l'espressione di tali geni riguarda
strutture nervose coinvolte nell’elaborazione somato-sensoriale e nella
regolazione  neuroendocrina,  come già  noto  per  il  cervello  di  ratto
adulto. Presi nel loro insieme i dati di espressione degli omologhi di
RXFP3 e RXFP4 nel pesce zebra, fanno ipotizzare che probabilmente
i meccanismi di regolazione dell' espressione genica e la loro funzione
ricapitolano i territori di espressione e la funzione dei soli due geni
presenti nel genoma dei mammiferi. Nel complesso, i dati ottenuti nel
mio  lavoro  di  tesi  mostrano  che  il  sistema  ligando/recettore  delle
relassine  è  attivo  durante  l'embriogenesi,  e  che  i  loro  territori  di
espressione  e,  probabilmente,  la  loro  funzione  nell'embrione  sono
conservati tra mammiferi e pesci.
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Introduction
2.0 INTRODUCTION
2.1 The relaxin family: structure and evolution
The members  of  relaxin/insulin-like peptide family are encoded  by
seven genes in humans and are all structurally related to insulin. In
particular, the peptide family is made of three relaxin genes (RLN1,
RLN2 and RLN3) and four insulin-like (INSL) peptide genes (INSL3,
INSL4,  INSL5  and  INSL6).  Relaxin  (RLN2),  the  first  identified
family  member  (Hisaw,  1926),  was  recognized  as  a  hormone
influencing the reproduction during normal pregnancy and parturition
in  many  mammalian  species  (reviewed  in  Bathgate  et  al.,  2006).
Currently,  it  is  known  that  RLN  is  involved  in  a  broad  range  of
reproductive  and  neuroendocrine  functions  (Bathgate  et  al.,  2006).
The relaxin family and  insulin  family belong  to  the insulin/relaxin
superfamily. The two families diverged early in vertebrate evolution
to form the relaxin peptide family, which includes several signalling
molecules that share similar secondary structures (Olinski et al., 2006
a/b). All members are synthesized as a pre-prohormone consisting of a
signal  peptide,  B-domain,  C-peptide,  and  A-domain  (Ivell  and
Einspainer,  2002).  In  particular,  like  all  other  secreted  peptide
hormones, relaxin is synthesized first as a pre-pro-peptide, with the N-
terminal pre- or signal sequence useful for the hormone secretion. The
nascent  pro-polypeptide  is  sequestered  into  the  lumen  of  the
endoplasmic reticulum of the hormone producing cells.  The cleavage
of the C peptide in vivo produces a mature peptide heterodimer of A-
and B-chains linked by two inter-chain and one intra-chain disulphide
bonds, between the six highly conserved cysteine residues in the A
and B chains (Marriott et al., 1992). The C-chain facilitates the folding
of the protein and the formation of the three disulphide bridges and it
is biologically active in the rat  central  nervous system acting as an
independent  signalling molecule  (Brailoiu et  al.,  2009) (Figure.  1).
Although they are structurally related  to  insulin,  the relaxin family
peptides produce their physiological effects by activating a group of
four  G  protein  coupled  receptors  (GPCRs),  relaxin  family  peptide
receptors 1–4 (RXFP1–4).
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Figure.  1:   Diagrammatic  structure  of  the  precursor  protein
generated  from  the  transcript  of  relaxin. Scheme  shows  the
intracellular  enzymatic  processing  of  pre-pro-relaxin  into  its  final
products.
The relaxin ligands and their receptors  were also analysed from an
evolutionary perspective,  in order  to understand how this signalling
system evolved in vertebrates.  Relaxins form together with insulins a
unique superfamily, whose members arose from a single ancestor gene
in  chordate  lineage  (Olinski  et  al.,  2006a;  Olinski  et  al.,  2006b).
Although  these  ligands  display  relatively  low  primary  amino-acid
sequence  identity,  phylogenetic  analyses  indicate  that  they  evolved
from a common ancestor RLN3-like gene (Hsu et al., 2003; Hsu et al.,
2005;  Wilkinson  et  al.,  2005b;  Good  et  al.,  2012).  After  the  two
rounds of whole genome duplications occurred in vertebrate lineage,
one single ancestor generated three relaxin genes (a fourth was lost).
One of these copies underwent a further duplication leading to a total
of four gene copies before tetrapods and teleosts divergence (Olinski
et al.,  2006a;  Good-Avila et al.,  2009).  Analyses  of whole genome
sequence  data  have  confirmed  that  three  rounds  of  whole  genome
duplication (WGD) have contributed immensely to the diversification
of  vertebrates  (Abi-Rached  et  al.,  2002;  Dehal  et  al.,  2005);  two
rounds of WGD (2R) occurred in early vertebrate evolution, while the
third round (3R) occurred at the base of the teleostean lineage. It has
been  proposed  that  the  major  vertebrate  novelties,  such  as  their
structurally  complex  nervous,  immune  and  reproductive  systems,
arose as a result of the massive amplification of genes that occurred
during  WGD. Indeed,  the  diversification  of  RLN/INSL  and  RXFP
2
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(Relaxin Family Peptide Receptors) genes was coincidental with 2R
events, suggesting that they probably played an important role in the
establishment of neuroendocrine and reproductive regulation in early
vertebrate evolution. In addition, it has been observed that the teleost-
specific 3R, strongly contributed to the genetic richness of teleosts and
their  biological  success  (Hoegg  et  al.,  2004;  Mayer  et  al.,  2005;
Yegorov et Good., 2012). The syntenic data analysis showed that in
teleost species, the six copies of relaxin family sequences are linked to
four loci: two loci are syntenic to human INSL5 (Park  et al., 2008),
and harbour teleost  insl5a  and insl5b; a locus syntenic to the human
relaxin cluster contains teleost rln; the locus syntenic to human RLN3
contains  rln3a  and  rln3b,  and the  locus  syntenic  to  human INSL3
contains teleost insl3 (Figure. 2). Thus, four genes were present in the
common ancestor of humans and teleosts. Of the six relaxin family
genes in teleosts, two arose as a result of the fish specific WGD. On
the contrary, in mammals, the RLN gene duplicated to give rise to two
additional members of the family, INSL4 and INSL6. In addition, in a
more  recent  duplication  of  the  RLN  gene,  specific  to  humans  and
anthropoid apes,  resulted in two copies  of RLN in primates,  called
RLN1 and RLN2,  with  RLN2 being functionally  equivalent  to  the
RLN in other mammals (Good Avila et al., 2009).
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Figure.  2:  Evolutionary  model  of  vertebrate  relaxin  genes  in
relation to the three rounds of whole genome duplication events
(R1-3). X  indicate pseudogenes or lost genes.
On the basis of ligand/receptor co-evolution, it was initially expected
that relaxin receptors should have been tyrosine kinase receptors as for
insulins, but, surprisingly,  they belonged to two unrelated and large
evolutionarily distant groups of GPCRs, the RXFP1/2 and RXFP3/4.
It was proposed that the signalling of the ancestral RLN/INSL peptide
in the chordate ancestor occurred via RXFP1/2-type receptors. Only at
the onset of 2R, the RXFP3/4-type receptor was recruited to produce a
signalling  system  encoded  by  3  genes  (2  receptors  and  a  single
ligand).  It  is  tempting  to  hypothesize  that  this  ancestral  2-receptor
system  had  a  dual  function  and  played  roles  in  both  reproductive
(using  RXFP1/2-type  receptor)  and  neuroendocrine  processes  (via
RXFP3/4-type  receptor)  (Yegorov  et  al.,  2012).  Then,  during
evolution,  only  those  genes  potentially  involved  in  neuroendocrine
4
Introduction
regulation  (as  rln3,  insl5  and  half  of  the  rxfp3/4-type  cognate
receptors) were retained after 3R in teleosts. The post-3R retention of
rln3 and insl5 paralogues was paralleled by the retention of duplicates
of  rxfp3-2  and  rxfp3-3,  suggesting  both  co-functioning  and  sub-
functionalization  of  their  neuroendocrine  roles  (Good  et  al.,  2012)
(Figure. 3).  
Figure.  3:  Evolutionary  model  of  vertebrate  receptor  genes  in
relation to the three rounds of whole genome duplication events
(R1-3).  X  indicate pseudogenes or lost genes.
2.2  The ligands
Only for a limited number of these peptides their physiological effects
have  been  defined.  Although  RLN  was  initially  identified  for  its
influence  on  parturition,  its  roles  has  now  been  recognized  in  a
number of physiological systems including cardiovascular, renal and
reproductive  systems,  in  fibrosis  and  allergic  responses  (Schwabe,
2000; Bathgate et al., 2002a, 2006a). 
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Relaxin-3 emerged prior to the divergence of fish and it is considered
as the ‘ancestral’ member of the relaxin peptide family. The relaxin-3
gene  is  highly  conserved  across  fish,  frogs,  rodents  and  primates,
suggesting that the peptide performs important physiological functions
(Bathgate  et  al.,  2002b;  Wilkinson  et  al.,  2005a;  Callander  and
Bathgate, 2010).  The RLN3 gene is mainly expressed in a restricted
area of rat,  mouse and monkey brain,  known as “nucleus  incertus”
(NI),  although  some  scattered  RLN3-expressing  cells  in  different
brain areas were also revealed (Bathgate et al., 2002a; Burazin et al.,
2002; Tanaka et al., 2005; Ma et al., 2007; Smith et al., 2010). Several
functions  of  RLN3  have  been  suggested  by  studies  on nucleus
incertus. This neural cell cluster has been emerging as a key element
of neural circuits regulating different processes such as arousal, stress
and  memory,  exploratory  navigation,  defensive  and  ingestive
behaviors,  and responses to neurogenic stressors (Goto et al.,  2001,
2005; Ryan et al., 2011; Olucha-Bordonau et al., 2011). In rodents, it
has been shown that RLN3 is involved in food intake, stress responses
and spatial memory (McGowan et al., 2005, 2006; Tanaka et al., 2005;
Hida  et  al.,  2006;  Ma  et  al.,  2009).  Interestingly,  the  expression
pattern of the RLN-3 gene is conserved during vertebrate evolution.
Indeed,  analysis  of  rln3a  gene  expression  during  zebrafish
embryogenesis showed that the gene is expressed in a region likely
homologous  to  the  mammalian  NI  (Donizetti  et  al.,  2008).  The
analysis  of the zebrafish paralogue gene  rln3b, evidenced that  both
genes were actively transcribed during embryogenesis and in the adult
tissues.  In  addition,  the  expression  pattern  analysis  evidenced
remarkable  differences  between  the  two  genes,  likely  as  a
consequence  of  a  sub-fuctionalization  process,  where  the  ancestral
expression  pattern  was  partitioned  between  the  two  paralogues
(Donizetti et al., 2009). For instance, during embryogenesis only rln3b
is expressed during gastrulation, while only rln3a is expressed in the
NI  at  the  larval  stage;  in  the  adult  organs,  both  genes  are  highly
expressed in the brain but only rln3b showed remarkable expression in
the testis (Donizetti et al., 2009). 
INSL-3 function has been strictly linked to reproduction, in fact, in
females, it has been shown to be involved in oocyte maturation and
germ cells survivor, while in male, is involved in descentus scrotalis
process (Nef et al., 1999; Zimmermman et al., 1999). 
6
Introduction
INSL-5 is expressed in human rectal and colon tissues and is likely
involved in both appetite stimulation and colon motility (Conklin et
al., 1999). 
Very little information are available regarding INSL4–6. 
2.3 The relaxin receptors
RLN/INSL peptides  interact  with two very  dissimilar  classes  of  G
protein-coupled receptors (GPCRs), named RXFP1, RXFP2, RXFP3
and  RXFP4.  Two  receptors,  LGR7  (renamed  RXFP1,  Hsu  et  al.,
2002)  and  LGR8  (renamed  RXFP2,  Kumagai  et  al.,  2002),  are
leucine-rich-repeat  containing  GPCRs  (LGR)  and  belong  to  the
glycoprotein receptor cluster. This cluster of receptors contains three
distinct LGR subgroups (type A, B and C), which have been defined
based on different number of LRR motifs, the absence or presence of
a  LDLa  motif  (low  density  lipoprotein  receptor  like  cysteine-rich
motif)  and the type-specific  hinge  region.  The RXFP1 and RXFP2
belongs  to  the  LGR  family  class  C  and  are  characterized  by  the
presence of a LDLa motif at protein N-terminus followed by a very
short  hinge region  and 10 LRR regions  (Hsu et  al.,  2002).  On the
contrary,  RXFP3 and RXFP4  (also known as SALPR or GPCR135
and GPCR142) are typical class A neuropeptide receptors and belong
to the chemokine receptor cluster of the  γ Group Rhodopsin family
(based on GRAFS classification, Fredrikkson et al., 2003). Signalling
pathways  of  RXFP3/RXFP4  result  in  the  inhibition  of  adenylate
cyclase  and  decrease  in  cAMP  accumulation  (Liu  et  al.,  2003a/b,
2005b). In contrast, the stimulation of RXFP1 and RXFP2  results in
the activation of adenylate cyclase and increase in cAMP level. 
Currently, it is known that there is cross-reactivity between the relaxin
peptides  and  their  receptors (Good,  2012), with  the  exception  of
INSL3 and RXFP2, which  in vivo represent  an exclusive hormone-
receptor pair  (Bogatcheva et al., 2003; Bathgate  et al, 2006; Halls  et
al., 2007). RXFP1 can be activated by both human RLN and H1-RLN,
as well as by RLN3. Similarly, RXFP3 can be activated by both RLN3
and RLN, and to a lesser extent by INSL5. RXFP4 is activated mainly
by INSL5,  although  can  also  cross-react  with  RLN3,  but  not  with
RLN,  nor,  of  course,  with  INSL3  (Figure.  4)  (Liu  et  al.,  2005;
Haugaard-Jonsson et al., 2009; Hossain et al., 2008).
7
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Figure.  4: Ligand–receptor  relationships  for  the  relaxin-family
peptides and their cognate receptors in Mammals. The thickness of
the arrows reflects the affinity and specificity of the interaction and
their secondary response.
RXFP1 has been shown to be expressed in the reproductive organs,
paralleling its  role as the receptor for relaxin.  In  humans, RXFP1
mRNA has been found in the ovary (Hsu et al., 2002), uterus (Hsu et
al., 2002; Luna et al., 2004; Mazella et al., 2004), placenta, testis and
prostate (Hsu et al., 2002). A similar distribution has been shown in
rodents (Hsu et al., 2000; Scott et al., 2004; Krajnc-Franken et al.,
2004;  Kubota  et  al.,  2004).  In  addition,  in  relation  to  relaxin’s
autocrine/paracrine  roles,  RXFP1  mRNA  has  been  found  in  the
brain, kidney, heart, lung, liver, adrenal, thyroid and salivary glands,
muscle, peripheral blood cells (Hsu et al., 2002). 
As expected, RXFP2 is expressed in the fetal gubernaculum of male
rats  (Kubota  et  al.,  2002)  and  mice  (Overbeek  et  al.,  2001)  in
accordance with its function as the receptor for INSL3. Additionally,
RXFP2-KO mice (Gorlov et al.,  2002) share the same cryptorchid
phenotype  as  the  INSL3-KO  mice  (Nef  and  Parada,  1999;
Zimmermann et al., 1999). In the adult, RXFP2 is expressed in post-
mitotic male germ cells,  where it  may have a role as a germ cell
8
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survival  factor  (Kawamura  et  al.,  2004; Anand-Ivell  et  al.,  2006),
and  in  Leydig  cells  and  epididymis  (Anand-Ivell  et  al.,  2006).
Additionally,  in  humans,  RXFP2  mRNA  has  been  shown  to  be
expressed  in  the kidney,  thyroid  gland,  muscle,  uterus,  peripheral
blood cells, testis, brain and bone marrow (Hsu et al., 2002). 
The RXFP3 gene expression was analysed by reverse transcriptase-
PCR in different tissues. The expression is restricted to the brain and
testis  of  rodents,  which  is  very  similar  to  the  tissue  expression
pattern of the human RXFP3, which is also expressed in thymus, and
adrenal gland (Liu et al., 2003). In rodents brain, the RXFP3 receptor
has been localized in some sensory areas of the brain as the olfactory
bulb,  sensory  cortex,  amygdale,  thalamus,  inferior  and  superior
colliculus, supraoptic nucleus, thalamic nuclei (paraventricular and
centromedial), the dentate gyrus of the hippocampus, dorsal raphe,
medial habenula and cortical  fields (Boels et al.,  2004; Liu et  al.,
2004;  Smith et al., 2010).  This RXFP3 neural network overlapped
the regional distribution of RLN3. This is a further evidence for the
interaction  between  RLN3  and  RXFP3  and  for  the  ability  of
RLN3/RXFP3 signaling to modulate “behavioral state” and an array
of circuits involved in arousal, stress responses, affective state, and
cognition (Smith et al., 2010).
RXFP4 gene is expressed in the mouse brain and testis, similarly to
the  human  homologue,  while  in  rats  and  dogs  both  RXFP4  and
INSL5  are  pseudogenes.  In  addition,  in  humans,  the  RXFP4
transcript has been detected in a broader range of tissues as kidney,
lung, and spleen (Liu et al., 2005). 
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In teleosts, many more genes have been identified for both ligands
and their receptors. It  has been supposed that Rln3b  is the cognate
ligand of Rxfp3-1, while Rln3a has specialized to function with two
receptors,  namely,  Rxfp3-2a  and  Rxfp3-2b.  Rxfp3-3a1,  Rxfp3-3a2,
and Rxfp3-3b are candidate receptors for insl5a, while Rxfp3-4 is the
receptor for insl5b; in zebrafish, the loss of rxfp4 was compensated
by the gain of  rxfp3-3a3,  which could interact with  insl-5b; rxfp2a
and  rxfp2b are  considered  the  receptors  for  insl-3; rxfp2-like  and
rxfp1 are  considered  the  receptors  for rln.  Although  for  the
circulating hormones we can, probably,  disregard the promiscuous
activation of other receptors at high ligand concentration, this may
not  be true  for  autocrine/paracrine  relationships  in  the vicinity of
sites of local synthesis, where local hormone concentrations can be
very  high.  It  is  also  important  to  recognize  that  although  some
circulating hormone concentrations can be quite low, most of these
receptors  can  be  activated,  although  briefly,  by concentrations  of
ligand  as  low  as  that  of  their  specific  ligand,  or  even  by
concentrations in the subpicomolar range (Halls and Cooper, 2010;
Ivell et al., 2009). 
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1.4  Aim
Studies  in  mammals  evidenced  an  intricate  ligand-receptor
relationship for relaxins system. Great advantages might result from
studies  on  relaxin  system  in  non-mammalian  model  organisms.
Moreover,  most  of  relaxin/receptor  system  studies  have  been
performed  in  adult  mammalian  organisms,  whereas  little  is  known
about relaxin function during vertebrate embryogenesis. 
Among experimental models, the  Danio rerio, also called zebrafish,
has emerged as one of the most useful  in many research areas and
particularly  for  embryonic  development.  By  using  zebrafish  as
experimental model, previous studies carried out in the laboratory of
Prof. Aniello, provided several interesting insights on relaxin system.
In  particular,  they  showed  that  the  rln3a/b  paralogue  genes,  are
differentially expressed in two territories of the developing zebrafish
brain. In addition, these data provided, for the first time, the evidence
of the nucleus incertus existence in fish, and supported the idea of an
ancestral function for Rln3 peptide as a neurotransmitter. (Donizetti et
al., 2008, 2009). 
Recent  phylogenetic  analysis  showed  that  the  numerous  vertebrate
RLN/INSL and RXFP genes are the consequence of  three rounds of
whole  genome  duplication  (WGD).  Diversification  of  the  relaxin
system was driven primarily by whole genome duplications (WGD,
2R  and  3R)  followed  by  almost  complete  retention  of  the  ligand
duplicates in most vertebrates but massive loss of receptor genes in
tetrapods.  For receptor,  the same phylogenetic  reconstruction led to
hypothesize that there was one ancestral gene for rxfp3/4 and one for
rxfp1/2, with differential reduction and expansion of gene repertoire
occurred independently in the tetrapod and teleost lineages (Yegorov
and Good, 2012). 
In  order  to obtain more data on relaxin/receptor system function in
vertebrate, and in particular, during embryonic development, the aim
of  this  dissertation  is  the  temporal  and  spatial  characterization  of
relaxin ligand  receptor  gene  expression during zebrafish embryonic
development. The experimental data will be discussed in comparison
with  the  data  reported  in  literature  for  the  mammalian  relaxin
ligand/receptor system. This will provide new insights into the roles of
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the relaxins and cognate receptor during zebrafish embryogenesis and
in the vertebrate evolution.
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3.0 MATERIALS AND METHODS
3.1 Experimental model
I use as experimental model the zebrafish (Danio rerio). It is a small
tropical fresh-water fish belonging to the  family Cyprinidae of  order
Cypriniformes. Due to its small size and ease of culture, the zebrafish
has  become  a  favourite  model  organism  for  biologists  studying
embryonic  development.  The development  of  the  zebrafish  is  very
similar  to  the  higher  vertebrates  embryogenesis,  including humans.
Moreover,  during  the  first  days  of  their  lives,  the  embryos  are
transparent.  The  zebrafish  model  organism  database  ZFIN
(http://zfin.org/) contains all the information about this experimental
model to develop and support integrated zebrafish genetic,  genomic
and  developmental  information.  The  zebrafish  embryonic
development is very rapid: at the first 24 hours after fertilization (hpf),
all major organs are formed and within 2 days the fish hatch and start
looking for food, after 3/4 months zebrafish are sexually mature and
can generate  new offspring.  In  particular:  there  are some landmark
stages: 
1-cell  (0-0.7  h):  newly  fertilized  egg.  The  nonyolky  blastodisc
segregates towards the animal pole. 
Cleavage (1-2.5 h): rapid divisions of the blastodisc that occur without
cell growth. 
Midblastula transition (3 h): division rate begins to slow and genes
begin to be transcribed. 
Epiboly (4-10 h): the blastodisc flattens into a blastoderm and spreads
to cover the yolk. Gastrulation (5-10 h): the blastoderm develops two
layers  (outer  ectoderm,  inner  mesendoderm)  by  involution.
Segmentation  (10-24  h):  somite  pairs  form  sequentially,  the  tail
develops and primary organ rudiments begin to form. 
Pharyngula  (from  1  day):  the  body  plan  characteristic  of  all
vertebrates  is  present  and  functionally  differentiated  cells
characterizing  the  nervous,  muscular,  and  circulatory  systems.
Hatching (from 3 days): embryonic development is complete. 
Feeding (from 4 days): The swim bladder fills and the larva actively
begins to seek prey (Kimmel, 1995). 
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3.2   Animals
Zebrafish were purchased from a local pet shop and housed in mixed-
sex groups in static tanks (approximately 20 L each) with airlift-driven
photoperiod  14h light/10h  dark  as  described  (Kimmel  et  al.,  1995;
Westerfield,  1995).  All  zebrafish  were  feeded  twice  a  day  with
tetrafood and artemia.  They were  treated with specific  protocol for
euthanasia methods and anaesthetized with tricaine  MS-222 (tricaine
methanesulfonate)  0.16mg/mL  in  Embryo  medium  (Westerfield,
1995).
3.3  Database search and sequence analysis
To identify the zebrafish rln gene, we used the amino acid sequence of
Anguilla japonica Rln  (BAJ22076.1) for a tblastn search in  D. rerio
nucleotide  National  Center  for  Biotechnology  Information  (NCBI)
database.  Amino acid sequence comparison of  D. rerio and various
teleost  Rln,  and  of  D. rerio Rln/Rln3 and  human  RLN/RLN3  was
carried  out  by  ClustalW  alignment  program  (Larkin  et  al.,  2007;
Goujon et al., 2010).  Instead, to obtain the exon and intron length and
the exon-intron organization of zebrafish and human  rxfp1 gene, we
used  Sequence  Viewer  function  of  the  National  Center  for
Biotechnology  Information  (NCBI)  web  site
(http://www.ncbi.nlm.nih.gov). The Map Viewer function of the same
web site  was  used  to  identify neighborhood genes  of  rxfp1 on the
zebrafish and human chromosomes.
3.4  RNA extraction and clean up 
Total  RNA from embryos and adult tissues were isolated using the
Trizol reagent (Invitrogen). RNA clean up was performed by using the
Qiagen  RNeasy  Mini  Kit  as  recommended  by  the  manufacturer.
Quantification  of  the samples  was  performed  by   nanodrop  2000c
(Thermo  Scientific).  RNA  quality  analysis  was  carried  out  on
electrophoretic gel agarose. For the preparation of the agarose gel, the
electophoretic apparatus was treated with NaOH 0.2M for 20 min and
washed with sterile double distilled water (ddH2O). 
3.5  cDNA synthesis.
First strand cDNA was synthesized from 3 ?g of  total RNA in a final
volume  of  20  ?L  by  reverse  transcriptase  Superscript  III  as
14
Materials and Methods
recommended  by  the  manufacturer (Invitrogen,  Milan,  Italy).  In
particular, both for cloning and expression pattern analysis, RNA from
2 to 72 hpf whole embryos and from different adult tissues was used.
After cDNA synthesis, the volume was brought to 50  ?L by adding
sterile ddH2O.
3.6  Polymerase chain reaction (PCR) and quantitative Real Time
PCR (qPCR) 
We performed PCR in 25 ?L reaction volume containing 0.2 mmol⁄
?L dNTPs, 10 pmol of each nucleotide, 2.5 ?L buffer (10 mmol⁄?L
Tris–HCl,  1.5  mmo⁄?L  MgCl2,  50  mmol⁄?L  KCl,  pH  8.3),  7%
dimethylsulfoxide (DMSO),  1.5  U TAQ DNA polymerase  (Sigma)
and X ?L of cDNA template.  PCR was carried out in a GeneAmp
PCR System 9700 (Applied Biosystems) and consisted of an initial
step at 95 °C for 3 min, followed by 38/40 cycles at 95°C for 1 min,
54⁄58 °C (depending on the primers pairs) for 1 min, 72 °C for 1 min
and a final cycle of extension at 72 °C for 10 min. In order to clone
specific sequences we used 7µL of cDNA as a template and 40 cycles
of amplification. To analyse the expression pattern of the relaxins and
receptors  transcripts,  we  used  4?L  of  cDNA  and  38  cycles  of
amplification, whereas, 1 ?L of cDNA and 36 cycles of amplification
for the rplp0 transcript. 
To perform qPCR, we designed specific primer sets for each gene by
using  the  Primer3  program  (Untergasser  et  al.,  2007
(http://www.bioinformatics.nl/cgibin/primer3plus/primer3pl
us.cgi). The  primers,  spanning  an  exon–exon  boundary,  amplify
products of about 100 bp in length. Blast searches were used to ensure
that  primers  were  specific  for  each  individual  gene.  The  real-time
PCR efficiency was calculated from the slope in the 7500 Software
v.2.0.1  (Applied  Biosystem).  The  relative  quantification  of  gene
expression was performed by real-time PCR using the SYBR Green
JumpStart  Taq  ReadyMix  (Sigma),  in  the Applied  Biosystem 7500
Fast  real-time  PCR  System.  The  following  conditions  were  used:
holding stage at 95 °C for 10 min, 40 cycles of 95 °C for 15 s and 60
°C for 1 min, followed by melt curve analysis to ensure that only a
single  PCR  product  was  amplified.  The  specificity  of  real-time
product amplification was also checked each time with high resolution
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gel  electrophoresis.  Each  25 µL reaction contained  12.5 µL SYBR
Green reagent ready mix 2X (Sigma), 0.25 µL ROX 100X (Sigma),
2.5 µL forward and reverse primer mix (4 mM) and 1 µL cDNA. To
confirm accuracy and reproducibility of real-time PCR the intra-assay
precision  was determined in  three repeats  within each run.  Control
reactions (without template) were run for each sample in triplicate.
??Ct-Method was used for relative quantification. The relative gene
expression  levels  were  normalized  to  the  rplpo transcript  in  the
respective sample. The ?Ct was calculated by subtraction of the Ct
value of the gene of interest from the Ct value of the reference gene
(rplpo).  ??Ct  was  calculated  by  subtracting  the  sample  ?Ct  to
calibrator ?Ct. As a calibrator, we used the sample that showed the
lowest level of transcript, (heart), 24 hpf for  rln transcript and 0 hpf
for insl-5a and insl-5b. The fold difference was calculated as 2-??Ct,
as  described  in  the  “Guide  to  Performing  Relative  Quantitation  of
Gene  Expression  Using  Real-Time  Quantitative  PCR”  (Applied
Biosystems).  The PCR products  obtained from different  stages  and
tissues  were  electrophoresed  on  1%-1.5%-2%  (depending  on  the
product  length)  agarose  gel  in  Tris-Acetate-EDTA (TAE)  1X with
EtBr 10 ?g/mL.
Table  1:  Primers  for  RT-PCR  with  relative  accession  number  of
genes:
gene Accession
number
Primers sequence
rln JN215212 For  5′GAGTGTAGCTCTGTCTGTCT-3′
Rev  5-TCAGACTCAGCGCAGCTC- 3′
For qRT 5′-GCGGAGAGCGGACACA-3′
Rev qRT 5′-CAGGAGAACCGACTTCAGGA-3’
rxfp1 NM_001190934 For 5’ TGTGAATGTTCCCAATTTCG 3’
Rev 5’ TTTGACCTTCTCGGGTCTTC 3’
rxfp3-1 NM_001128788 For 5’  AGCGACGATTTTATCCAAGG 3’ 
Rev 5’ CACTTTGGAGCGCCTTTTAG 3’
For 1 5’  AACGCGATTTTCTCAACGAC 3’
Rev1 5’ CCGTTCTGTTTGGAATCTGG 3’
rxfp3-2a XM_001346785  For 5’ AACATCTCTGTAGCGCATG 3’
Rev 5’ CGCGGAGCAGAGGTATAC 3’
For1 5’ GCTCTCTGTCCTCTTCTTTGC 3’
Rev1 5’ CCCAAACTAGCCCACTTGAC 3’ 
rxfp3-2b NM_001083879  For 5’ CTCCGTTTACATCCTTTGAC 3’ 
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Rev1 5’ TGCTTCGTCCTGTCAATC 3’ 
For1 5’ GCGTGGCAAGGTACTACTCC 3’ 
Rev1 5’ GCTGCTGCTCTGCGACG 3’ 
rxfp3-
3a1
ENSDARG000000
69028
For 5’ CATTTAACACTATCGCAGAGAG 3’ 
Rev 5’ CAGTCCACTGTCCAATTTGG 3’
For1 5’ CCCTTCCAGAAAGAAGTCTGTG 3’ 
Rev1 5’ GTCGCCAGGATCCACAAC
rxfp3-
3a2
ENSDARG000000
62111
For 5’ TCAACAACAGTTTGGTAGAATG 3’ 
Rev 5’ AACCCATTAATCACGGAAAG 3’ 
For1 5’ CAGAGGCTGTCAATGAGG 3’
Rev1 5’ TGACGGCGATGAGTATTACG 3’ 
rxfp3-
3a3
ENSDARG000000
69246
For 5’ CTTCAACACGGGCTTTGC 3’ 
Rev15’AAACAATACATCATCGTGTGAT 3’
For1 5’ GTGGGTGCTCGCTACAGTC 3’
Rev1 5’ AGACTTCTCTCCGACCACAC 3’ 
rxfp3-3b ENSDARG000000
59348
For 5’ AGGATCGCACGCGGTATAAGC 3’
Rev 5’ GTTCAGGCAGCTGTTGGAGTG 3’
rln3a NM_001037803.1 For 5’ AAAGCACAGGTAGACCATCGG 3’
Rev1 5’ TGCAGCCCCATTTGCAGCAGG 3’
ff1b NM_131794 For 5’ ACGGTGATGGACTTCAGAGC 3’
Rev 5’ ATCGCCCACCTTTAGTTCCT 3’
Rxfp2-
like
ENSDARG000000
68731
For 5’ TGGCCAGTTTATCTGTTAGAAGG 3’
Rev 5’ TGATGCCCAGAGAGATGAAA 3’
Rxfp2a ENSDARG000000
32820
For 5’ AATACAGCAAACGCGCATC 3’
Rev 5’ TCTACTGAAGGCTCGGCTTG 3’
Rxfp2b NM_200443.1 For 5’ CAGGATTTTTAGGAACCCAGTG 3’
REV 5’TCCACTGAAAGCCTGAATGG 3’
Insl5a NM_001037669 For 5’ GATCCAGAAGACCCGAGAGA 3’
Rev 5’ TGATTACTGCCTTCCACCAAC 3’
For qRT5’TCAACTCTCTCCGAGATCCTCAAC3’
RevqRT 5’ GTGCGGCAGAGAGTTTATCC-3’
Insl5b NM_001128556  For 5’ GAAGACATTCTGAGGTCAG 3’
Rev 5’ CGACGTTTGAACATTTCTCAT 3’
Rev qRT CCAAACTGAAGACCCCGTAA-3’
rplpo NM_131580 For 5’ CAAGGCCGTCGTGCTCA 3’
Rev 5’ CAGCGTGGCCTCGCTG 3’
For qRT 5’CTGGAAAACAACCCAGCTCT-3’
Rev qRT 5’ CGGACCTCAGTCAGATCCTC-3′
3.7  Cloning in pGEM®-T Easy Vector
Amplicons  were  cloned  into  pGEM®-T  Easy  Vector  (Promega)  as
recommended  by  instruction  manual.  The  reaction  have  been
optimized using a 3:1 molar ratio of the insert DNA to the vectors. 
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3.8  RNA Probes for in situ hybridization experiments
All  solutions  were  prepared  with  DEPC  water  and  RNase-free
chemicals.  RNA probes  were  obtained  by  in  vitro  transcription  of
inserted DNA into pGEM®-T Easy Vector,  the linearized rln cDNA-
containing  plasmid,  using  DIG  RNA  Labeling Kit  (Roche
Diagnostics)  as  recommended  by  the  manufacturer.  The  RNA
riboprobe was precipitated by adding 5 ?L of LiCl 4 M and 150 ?L
absolute ethanol and incubation at −20 °C over night. The pellet was
washed with ice cold 70% ethanol and allowed to air-dry. The probe
was resuspended in 50 ?L of DEPC water.
3.9  Whole mount embryo in situ hybridization
The  embryos  were  grown  in  embryo  medium at  28.5  ºC  until  the
desired  developmental  stage.  After  chorion  removal,  the  embryos
were fixed in   4% paraformaldehyde  for two hours. When required,
the pigmentation was removed by photobleaching. After dehydration
with progressive passages in MeOH, the embryos were stored at -20
ºC.
For  the  in  situ hybridization  experiments,  we  used  an  antisense
digoxigenin  (DIG)-labeled  RNA  probe.  The  corresponding  sense
RNA probe was used as a control for the specificity of hybridization
signals.  Whole  mount  in  situ hybridizations  were  carried  out  as
reported in Thisse et al, (2004) with the following modifications: after
the protease K digestion and fixing in paraformaldehyde, the embryos
were incubated in triethanolamine (0.1 mmol/L pH 7.0) for 5 min and
twice  in  triethanolamine-acetic  anhydride  solution  for  5  min;  the
embryos  were  hybridized  at  60  °C  for  40  hr  in  the  following
hybridization mix: HM [50% formammide, 5X saline sodium citrate
(SSC),  0.1%  Tween  20,  citric  acid  to  pH  6.0,  5  mmol/L
ethylenediaminetetraacetic acid (EDTA), 1X Denhardt’s solution and
Heparin  50  µg/mL,  tRNA  500  µg/mL];  after  hybridization,  the
following washes were performed: 15 min in 75% HM/25% 2X SSC
at 60 °C, 15 min in 50% HM/50% 2X SSC at 60 °C, 15 min in 25%
HM/75% 2X SSC at 60 °C, two washes of 10 min in 2X SSC at 65
°C, four washes of 10 min in 0.2X SSC at 65 °C; the incubation with
anti-DIG  antiserum  was  performed  overnight  at  +4  °C  in  the
following  antibody  solution:  100  mmol/L  Tris–HCl  pH  7.5,  150
mmol/L NaCl, 2% blocking reagent  (Roche),  2 mg/mL BSA, 0.1%
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Tween, 5% lamb serum. Finally, the digoxigenin-labeled cRNA probe
was detected using anti-DIG-conjugated alkaline phosphatase activity
and  4-nitroblue  tetrazolium  chloride/5-bromo-4-chloro-3-indolyl-
phosphate  (NBT/BCIP)  (Roche)  as  substrate.  For  double  in  situ
hybridization experiments, an rln3a fluoresceine-labeled RNA probe
was  used.  The  detection  was  performed  by  anti-FLUO-conjugated
alkaline phosphatase activity and INT/BCIP (Roche) as described in
Donizetti  et  al,  (2009).  In  situ hybridization  experiments  were
performed  at  least  in  triplicate  for  each  embryonic  developmental
stage. 
For transversal sections (3 ?m) via ultramicrotome, the embryos were
washed  in  PBT for  10  min  (2  times)  and  were  dehydrated  by  the
following  solutions:  EtOH  25%/PBT  75%,  EtOH  50%/PBT  50%,
EtOH 75%/PBT 25%,  EtOH 80%/PBT 20%,  EtOH 95%/PBT 5%,
EtOH 100%. After dehydration, the embryos were treated by 100%
propylene oxide (4 times for 5 min), propylene oxide 75%/epon 25%
(30 min), propylene oxide 50%/epon 50% (30 min), propylene oxide
25%/epon 75% (30 min), epon 100% (30 min), epon 100% (overnight
at 70 °C).
Table 2: Proteinase K times for each zebrafish embryonic stage.
Embryonic stages times for protease K
8     hpf 1’ 
16   hpf 5’ 
20   hpf 7’ 
24   hpf 10’ 
36   hpf 15’ 
40   hpf 17’ 
48   hpf 20’ 
72   hpf 25’ 
96   hpf 30' 
120 hpf 35' 
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3.10  In situ hybridization on zebrafish adult tissues.
Danio rerio tissues were treated according to the following protocol:
fix in Bouin 72h, wash in 70% EtOH 30 min, 4 times, washed in 80%
EtOH 1h, dryed in 95% EtOH 30 min for 8 times, 100% EtOH 15 min
for 4 times, Xylene 10 min for 4 times, paraffin embedding 42h. The
slides were treated in xylene 10 min two washes, in 100% EtOH for 5
min,  95% EtOH,  80% EtOH,  70% EtOH,  50% EtOH EtOH,  30%
EtOH 2 min each step in DEPC H2O. The slides were incubated in
Proteinase K 10 mg/ml in 20 mM Tris-HCl pH 7.2, 1 mM EDTA 20
min  at  RT  or  10  min  at  37  ºC.  After,  the  slides  were  fixed  in
paraformaldehyde in 0.5 M NaCl, 0.1 M MOPS pH 7.5, 30 min RT,
after they were washed in tris-glycine 5 min. Then, the slides were
refixed in paraformaldehyde and treated with 10 mM triethanolamine
in PBS 1X in DEPC and acetic anhydride. The tissues were washed in
2X SSC 2 min and in Tris-glycine 30 min at RT. The tissues were
hybridized for 3 h at 50 ºC as follow: 40% formamide, SSC 5X, 1X
Denhardt, Testis salm 100 µg/mL with the probe: 80 ng probe to slide.
The hybridization solution is denatured at 95 ºC for 2 min, then kept
on ice until hybridization at 50 ºC. The slides were washed in 2X SSC
20 min at RT, washed in 1X SSC and 20% Formamide at 60 ºC for 40
min and washed in 0.5 X SSC and 20% Formamide at 60 ºC 40 min.
After, the slides were washed in NTE buffer 0.5 M NaCl, 10 mM Tris-
HCl pH 7.0, 0,5 mM EDTA for 15 min at 37 ºC. The tissues were
washed in  NTE buffer  + 10?g/ml RNase  A,  at  37 ºC 30 min and
washed in NTE buffer at 37 ºC 15 min. The tissues were washed in
0.5X SSC and 20% Formamide for 30 min at 60 ºC and washed in 1X
SSC for  30  min  at  RT.  The  slides  were  incubated  with  100  mM
Tris/HCl  pH  7.5,  150  mM  NaCl  and  Ab  (diluted  1:2000  anti-
digoxigenin Ab, and anti-fluorescein Ab 1:1000 Roche). For detection
the  slides  were  washed  in  TBS  after  in  Tween  20  and  10  min
Levamisole. The slides were washed with NMT detection buffer for 5
min at RT, incubated in NMT, NBT/BCIP (Roche). Wash slides in 1X
PBS and 1 mM EDTA, 30 minutes. the slides were dehydrated with
50% EtOH, 70% EtOH, 80% EtOH, 90% EtOH, 100% EtOH, after
washes in xylene. Close the slide through clearing agents to a point at
which a permanent resinous substance beneath the glass coverslip, or
a plastic film, can be placed over the section.
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4.0  RESULTS
4.1 RELAXIN LIGANDS
4.1a  Relaxin
We  started  with  searching  for  the  rln coding  region  in  D.  rerio
genome. We  used  the  amino  acid  sequence  of  A.  japonica  Rln
(BAJ22076.1) as a bait for a tblastn search in the D. rerio nucleotide
collection database of the NCBI website. We found a genomic region
containing the putative  rln coding region  that  we used to  design a
couple of primers in the 5′UTR and 3′UTR of zebrafish rln transcript.
For the RT-PCR amplification, we used the corresponding cDNA of
RNA extracted from embryos at 48 hpf (hours post fertilization) and
adult  brain.  The  resulting  amplicon  (575  bp)  was  cloned  and
sequenced  (AC:  JN215212)  to  confirm  the  specificity  of  the
amplification  reaction.  The  corresponding  translated  amino  acid
sequence was used to retrieve orthologue Rln sequence in other fish
species  by  a  tBLASTn  search  in  the  NCBI  database
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). In Figure 5A, it is shown the
overall  amino acid sequence alignment  of  zebrafish Rln with some
orthologue sequences found in different fish species. As expected, the
B and A domains, which should be retained in the mature molecule,
showed higher amino acid sequence conservation than the C domain.
In  the  Figure  5B,  we reported  the  B and  A domains  alignment  of
zebrafish  Rln,  Rln3a  and  Rln3b, and  human  RLN1/2  and  RLN3
proteins.  The B domain of  zebrafish  Rln  sequence  showed greater
similarity to  the  corresponding domain of  zebrafish  Rln3a/b (80%)
and human RLN3 (76%) than to  the B domain  of  human RLN1/2
(44%). Differently, the zebrafish Rln A domain showed relatively low
amino acid sequence similarity when compared to the corresponding
sequence  of  the  other  aligned  proteins  (≤  45%)  (Figure.  5B).  The
greater  diversity of the A domain respect  to B domain may reflect
different  binding  specificity  for  the  relaxin  receptors  compared  to
Rln3 peptides. The identification of zebrafish rln orthologue gene was
further  supported  by  the  exon-intron  organization  and  the  syntenic
analysis. In particular, the analysis of genomic sequence showed that
rln gene is split into two exons by an intron sequence of 2845 base
pairs length (Figure. 5C). In line with data reported by Good-Avila et
21
Results
al.  (2009),  the  rln gene was found on the chromosome 21 between
Jak2 and  C9orf46 genes  (Figure.  5C),  showing conserved  syntenic
organization compared to other teleost orthologues. 
Figure. 5.  Comparative analysis of Rln amino acid sequence and
gene structure. Amino acid sequence alignment of the zebrafish  rln
with the ortologue sequence of other teleost species (in panel A). The
number on the right indicates the amino acid sequence length. Amino
acid sequence alignment of B and A domain of zebrafish Rln, Rln3a/b
and human RLN3 and RLN1/2 (in panel B).  Genomic organization
and syntenic analysis of the zebrafish rln gene (in panel C). Identical
amino acids are indicated by asterisks, conservative substitutions are
shown by colons and semiconservative substitutions by dots. Gaps in
the sequence are represented by dashes. The alignments  in A and B
were carried out by ClustalW software with default parameters. OlRln,
Oryzias  latipes Relaxin  (NP_001098341.1);  GaRln,  Gasterosteus
aculeatus Relaxin (ENSGACG00000017364);  TnRln,  Tetraodon
nigroviridis Relaxin (ACA13590.1); TrRln, Takifugu rubripes Relaxin
(NP_001092113.1);  DrRln,  Danio  rerio Relaxin  (JN215212);
DrRln3a,  D.  rerio  Relaxin3a  (NP_001032892);  DrRln3b,  D.  rerio
Relaxin3b  (NP_001108535);  AjRln,  Anguilla  japonica  Relaxin
(AB576118);  HsRLN1,  Homo  sapiens  Relaxin1  (NP_008842);
HsRLN2, Homo sapiens Relaxin2 (NP_604390); HsRLN3, H. sapiens
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Relaxin3 (AAQ88548). The percentage value indicates the amino acid
sequence similarity. 
To evaluate the  rln transcript level during embryogenesis and in the
adult  tissues,  we  carried  out  RT-qPCR  experiments.  During
embryogenesis,  the  rln transcript  was  revealed  in  all  the  analysed
stages, including cleavage stage (2 hpf), suggesting a maternal origin
of  the  transcript  (Figure.  6A).  The  transcript  level  decreased  from
cleavage  (2  hpf)  to  the  sphere  stage  (4  hpf),  whereas  it  newly
increased  at  the  blastula  stage  (8  hpf)  (Figure.  6A).  Subsequently,
from  the  low  level  detected  during  somitogenesis  (16  hpf),  a
progressive increase in the transcript  amount was revealed until the
larval stage (72 hpf) (Figure. 6A). In the adult, the rln transcript was
detected in all the analysed tissues; in particular, a relatively higher
transcript amount was evidenced in the brain than in the other tissues
(Figure. 6B). 
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Figure. 6.  Expression pattern of the  rln gene by RT-qPCR. Fold
difference  of  relaxin gene  expression  at  indicated  stages  as  hours
postfertilization (hpf) (A). Fold difference of relaxin gene expression
in  various  tissues  of  adult  zebrafish  (B).  Relaxin expression  levels
were  normalized  against rplpo transcript.  Black  bars  represent  the
standard deviation.
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Moreover,  in  order  to  identify  embryonic  territories  of  rln gene
expression,  we  carried  out  whole  mount  in  situ hybridization
experiments on zebrafish embryos at different developmental stages.
In particular, to detect  rln mRNA, we used a DIG-labeled antisense
riboprobe, and, to control the specificity of the hybridization signals,
we used the corresponding DIG-labeled sense riboprobe. Likely as a
consequence  of  low  transcript  amount,  the  appearance  of  specific
hybridization signals required relatively long staining reaction time.
That determined the appearance of aspecific background staining. In
light of that, we only took into account hybridization signals that were
clearly evidenced by comparison between sense (Figure. 7A, C, F, H,
J, L, P) and antisense riboprobe experiments (Figure. 7B, D, E, G, I,
K, M, Q, R, S, T). From fertilized eggs to somitogenesis, we revealed
broadly distributed hybridization signal (data not shown). Starting at
pharyngula stage (24 hpf), we detected restricted rln-expressing cells
in the olfactory placodes (Figure.  7B). At late pharyngula stage (48
hpf)  rln transcript continued to be detected in the olfactory placodes
(Figure. 7G). Later, the transcript was still revealed in the same cell
groups  at  the larval  stage  (72 hpf)  (Figure.  7I),  whereas  it  was no
longer detected in that region at the post-embryonic analysed stages
(data not shown). At the 24 hpf embryonic stage, rln gene expression
was also revealed in the posterior branchial arch region (Figure. 7D).
This  hybridization signal  was  evident  until  30  hpf,  when new  rln-
expression territory was revealed close to the otic vescicle (Figure.
7E). At larval and post-embryonic stages, new expression territories
were  detected.  In  particular,  the  gene  expression  was  revealed  in
restricted  brain  regions,  such  as  preoptic  area  (Figure.  7K)  and,
posteriorly, in some scattered hindbrain cells (blue arrowheads) and in
a bilateral  cell cluster  in the pons region, as shown by dorsal  view
(Figure. 7M). The same hybridization signals were also revealed at 96
hpf and 120 hpf  (data not shown). The bilateral  cell cluster in the
pons region appeared similar to that previously described by our group
for the rln3a expression pattern analysis (Donizetti et al., 2008; 2009).
By  double  in  situ hybridization  experiments,  we  showed
colocalization  of  rln and  rln3a  transcripts.  In  this  regard,  we  used
antisense rln DIG-labeled and rln3a fluorescein-labeled cRNA probe.
The  rln3a  riboprobe  marked  the  anterior  cell  cluster  in  the central
midbrain  tegmentum  (orange  arrow),  that  we  hypothesized  as  a
homologous region of mammalian periaqueductal gray (Donizetti et
25
Results
al. 2008; 2009), whereas  rln riboprobe marked scattered cells in the
hindbrain  region  (blue  arrowheads)  (Figure.  7N).  In  addition,  both
riboprobes  co-localized  in  the  cell  cluster  of  the  pons  region
(blue/orange  arrowhead  in  Figure.  7N),  as  better  evidenced  by the
magnification  (Figure.  7O).  At  96  hpf,  a  new signal  was  revealed
around the anterior commissure (Figure. 7S). Starting at larval stage
(72 hpf), the rln transcript was also detected in the pancreatic region,
as shown in a lateral view of the embryo (Figure. 7Q). Later, rln gene
expression  persisted  in  the  pancreatic  region  at  96  hpf  (data  not
shown)  and  120  hpf,  when  rln transcript-positive  cells  appeared
circularly  distributed  (Figure.  7T).  An  additional  signal  was  also
revealed in thyroid gland at 96 hpf (Figure. 7R) and 120 hpf (data not
shown).
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Figure. 7. Localization of the rln transcript by whole mount in situ
hybridization  at  indicated  stages  of  zebrafish  embryogenesis.
Control experiments with rln sense riboprobe (A, C, F, H, J, L, P). In
situ hybridization experiments with rln antisense riboprobe (B, D, E,
G, I, K, M, Q, R, S, T). Double in situ hybridization experiments with
rln and rln3a antisense riboprobes (N, O). Lateral view of embryo at
early pharyngula stage, head region (A, B). Lateral view of embryo at
early pharyngula stage, particular of pharyngeal arches region (C–E).
Ventral view of embryo at late pharyngula stage, head region (F, G);
Magnification of the olfactory placode region at larval stage (H, I).
Lateral (J, K) and dorsal view (L, M, N, O) of brain embryo at larval
stage; (N) double in situ hybridization for rln transcript (blue signal)
and  rln3a transcript (orange signal) at larval stage; magnification of
rhombencephalic  region where  rln and  rln3a transcripts colocalized
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(O). Particular of anterior trunk region (P, Q). Lateral view of head
region of post-embryonic zebrafish (R). Lateral view of anterior brain
region of post-embryonic zebrafish (S). Magnification of pancreatic
region  of  post-embryonic  zebrafish  (T).  Black  arrowhead  indicates
rln-expressing  cells  near  otic  vescicles;  blue  arrows  indicate
rhombencephalic  cells.  Blue/orange  arrowhead  indicates
colocalization of rln and rln3a transcripts. ac, anterior commissure; br,
branchial  region;  e,  eye;  op, olfactory placode;  ov, otic vescicle;  p,
pancreas  region;  po,  preoptic  region;  pt,  prethalamus;  r,
rhombencephalon; t, telencephalon; ty, thyroid.
4.1b INSL-5a and INSL-5b
Furthermore, we analyzed the two zebrafish  insl-5 paralogues genes,
insl-5a  and  insl-5b.  To  have information  on the  insl-5a  and insl5b
transcript  level  during  embryogenesis,  we  carried  out  RT-qPCR
experiments on total RNA extracted at various developmental stages.
The  insl-5a and  insl-5b transcripts are present in all the embryonic
stages, including cleavage stage (2 hpf), suggesting a maternal origin
(Figure. 8A). The insl-5a transcript amount increased at sphere (4 hpf)
stage,  and  resulted  at  similar  level  at  blastula  (8  hpf)  and  the
somitogenesis  stage  (16  hpf).  Subsequently,  the  transcript  level
decreased  from early  pharyngula  (24  hpf)  to  larval  stage  (72  hpf).
insl-5b showed a different expression pattern compared to insl-5a. We
observed the highest transcript level at cleavage stage (2 hpf) (Figure.
8).  The RNA amount  decreased  until  blastula  stage  (8  hpf)  to  re-
increase at somitogenesis stage (16 hpf). At early and late pharyngula
stage  (24  hpf and 48 hpf),  we observed  a relatively low transcript
level,  while  at  larval  stage  (72  hpf),  a  new increase  was  revealed
(Figure. 8).
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Figure. 8. Expression pattern of the paralog gene insl-5a and insl-
5b RT-qPCR. Fold difference of insl-5a and insl-5b gene expression
at  indicated  stages  as  hours  post-fertilization (hpf).  The expression
levels were normalized against  rplpo transcript. Black bars represent
the standard deviation.
To  localize  the  expression  territories,  we  carried  out  in  situ
hybridization  on  insl-5a  and  insl-5b  paralogues  genes  at  different
zebrafish development stages. We observed a restricted hybridization
signal for  insl-5a starting from 72 hpf (larval stage) until 96 hpf. In
particular,  gene  expression  was  revealed  in  intestinal  cells  and
pancreatic region (Figure. 9).  On the contrary,  insl-5b showed a very
faint hybridization signal and only at 96 hpf, we were able to detect a
specific and restricted signal in intestinal cells (Figure. 9).  To better
characterize the intestinal cell  types  where  the two paralogue genes
are  expressed,  we  performed in  situ hybridization  experiments  on
sections of  adult zebrafish intestine  tissue (Figure. 10 and 11). As a
control,  we carried out hybridization experiments using RNA sense
probe (Figure.  10A and 11A). The two genes showed expression in
two different cell types. In particular, insl-5a is expressed in the goblet
29



Results
series of primers to amplify (by RT–PCR experiments) and clone the
full-length cDNA coding region of the zebrafish Rxfp1 receptor. The
PCR products were cloned and sequenced to confirm the full-length
cDNA  coding  region  sequence  (HM135955).  The  alignment  of
deduced zebrafish and human RXFP1 protein showed 76% amino acid
sequence similarity (Figure. 12). All of the characterizing extracellular
domains of the RXFP1 receptor are present in the zebrafish sequence.
As displayed  in Figure  12,  the high degree  of  conservation is  also
reflected  in  potential  N-glycosylation  sites,  in  potential
phosphorylation  sites and in  key amino acid residues  important for
receptor  activation  and  interaction  with  RLN2  (Bullesbach  &
Schwabe 2005; Halls et al.,  2007; Hopkins et al.,  2007; Yan et al.,
2008). 
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Figure.  12. Amino  acid  alignment  of  the  human  RXFP1
(HsRXFP1;  NP_067647)  and  zebrafish Rxfp1  (DrRxfp1;
HM135955)  proteins  using  ClustalW. The  amino  acid  residues
important  for  receptor  activation  are  in  green.  The  potential  N-
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glycosilation sites are indicated in blue. The putative phosphorylation
sites  are  indicated in  pink.  The circles  indicate  the residues  of  the
relaxin binding site  in the leucine-repeats  of  the receptor.  Identical
amino acids are indicated by asterisks (*), conservative substitutions
are shown by colons (:),  and semiconservative substitutions by full
points (.). Gaps in the sequence are represented by dashes. LDLa is the
low density lipoprotein module; LRR indicates the leucin rich region;
TM is the transmembrane region.
In addition, we compared the genomic sequences of the zebrafish and
human  RXFP1  genes.  The  comparison  of  the  gene  order  in  the
neighborhood  of  the  rxfp1 in  the  zebrafish  and  human  genome
supported  the  idea  that  the  identified  zebrafish  sequence  is  the
homologue of the human RXFP1 receptor (Figure. 13b). The human
RXFP1 gene is made up of 18 exons, where the first and second exons
are separated by 50.6 kb. The zebrafish rxfp1 gene is organized in 17
exons and, similarly to the human gene, the first exon is far from the
second, being separated by 58.2 kb (Figure. 13a). The first exon of the
zebrafish gene contains the coding region for both the signal peptide
and LDLa module, whereas in the human genome the sequences for
the  two domains  are  split  into  two exons  (Figure.  13a).  The other
exons  of  the  human  and  zebrafish  gene  are  highly  conserved  and
encode for the same amino acid region (Figure. 13a). 
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Figure.  13.  Schematic representation of  the human RXFP1 and
zebrafish rxfp1. Exon⁄intron organization  of the human RXFP1 and
zebrafish rxfp1 on the corresponding chromosomal region (a). The red
lines indicate the difference in the first zebrafish rxfp1 exon, which is
split into two exons in the homologue human gene.  The blue lines
indicate the correspondence of the remaining exons in the two genes.
Analysis of the neighborhood of the rxfp1 gene in the zebrafish and in
the human genome (b). The homologue genes are indicated with the
same colours.
To look into the temporal  expression pattern of the zebrafish  rxfp1
gene during embryogenesis, we carried out RT–PCR experiments on
total RNA from different developmental stages. As shown in Figure
14a, the rxfp1 transcript is present in all analysed stages with higher
level  at  the  blastula  (4  hpf)  and  late  pharyngula  stages  (48  hpf)
(Figure. 14). The same RT–PCR analysis was carried out for the adult
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organism,  by using RNA extracted  from different  zebrafish  tissues
(Figure. 14b). Results of PCR amplification showed that the gene is
broadly  expressed,  being  actively  transcribed  in  all  the  analysed
tissues. 
                    
Figure. 14. Temporal expression pattern of zebrafish rxfp1 by RT-
PCR  experiments. Analysis  of rxfp1 gene  at  different  embryonic
stages,  indicated  on top as  hours  post  fertilization  (a).  Analysis  of
rxfp1 gene expression in the adult zebrafish tissues (b). The control
PCR reaction without cDNA template are indicated as C in (a) and (b).
Amplification  of  rplp0 cDNA fragment  was  a  control  of  RT–PCR
sensitivity in the assays.
We carried  out  whole  mount  in  situ hybridization  experiments,  in
order  to analyse  the embryonic territories of  rxfp1 gene expression.
During the early developmental stages (4 hpf), the transcript appeared
widely  distributed  in  embryos  (Figure.  15a),  whereas  during
somitogenesis (16 hpf) the expression was restricted in the brain with
a  strongest  hybridization  signal  in  the  diencephalic  region  (Figure.
15b, c). Starting from the pharyngula stage (24 hpf), the expression
was evidenced in the epiphysis and in the branchial arch region, as
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clearly shown by a lateral view of the embryo (Figure. 15d). A dorsal
view of the head showed that the rxfp1 transcript was also present in
the  diencephalic  region  and  in  the  terminal  nerve  (Figure.  15e)  as
better shown in the magnification (Figure. 15f). At the late pharyngula
stage  (48  hpf),  the  rxfp1 gene  expression was  still  detected  in  the
terminal nerve and in the epiphysis but not in the first branchial arch
(Figure. 15g). In addition, a new expression territory was apparent in
the postoptic region and in the hypothalamic region (Figure. 15g). A
ventral view of the embryo highlighted the signal in the terminal nerve
between the olfactory bulb and olfactory placode, and in two distinct
cell groups in the postoptic region and, more caudally, in the ventral
hypothalamic  region  (Figure.  15h).  At  this  stage,  other  new  rxfp1-
expressing  cells  were  detectable  in  the  rhombencephalic  region
(Figure. 15i). At larval stage (72 hpf), the rxfp1 expression persisted in
the terminal nerve (Figure. 15j, k). The lateral and dorsal view of the
brain clearly  showed  rxfp1-expressing cells  in  the epiphysis  (better
shown  in  the  inset  of  Figure  15j),  in  the  postoptic  region,  in  the
posterior  tuberculum,  in  the  hypothalamus,  in  the  optic  tectum,
tegmentum ⁄ pons region and medulla region (Figure. 15j, l, m).
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Figure.  15.  In  situ localization  of  rxfp1 transcript. Embryo  at
blastula stage (a).  Embryo at somitogenesis stage (b, c).  Embryo at
early pharyngula stage (d–f). Embryo at late pharyngula stage (g–i).
Embryo  at  larval  stage  (j–m).  The  black  arrowhead  indicates  the
terminal nerve. The red arrowheads indicate cells in the optic tectum.
The  red  arrows  indicate  cells  in  the  rombencephalic  region.  ba,
branchial arch; d, diencephalic region; e, epiphysis; hy, hypothalamic
region; ob, olfactory bulb; op, olfactory placode; ot, optic tectum; ov,
otic  vescicle;  po,  preoptic  region;  pt,  posterior  tuberculum;  t⁄p,
tegmentum ⁄pons region.
4.2b  rxfp2
To analyze  the temporal expression pattern of  rxfp2 paralogue genes
during  embryo  development,  we carried  out  RT–PCR experiments.
We observed that only one of the three rxfp2 paralogue genes, rxfp2-
like,  was expressed during zebrafish development.  In  particular,  we
detected the transcript at late pharyngula and larval stage (Figure. 16). 
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transcript  amount,  we  were  unable  to  obtain  specific  hybridization
signal.
For  rxfp3-1 gene,  at  24  and  48  hpf,  the  expression  was  clearly
evidenced in a cell group in the middle/ventral region of the zebrafish
trunk (Figure. 19). The dorsal view of the embryo showed that the cell
cluster was located asymmetrically to the right of the notochord, in a
position compatible with interrenal gland (Figure. 19).   Moreover, at
larval stage, we observed that the gene expression is localized in the
rhombencephalic region (Figure. 19D, E). 
Figure.  19.  Whole  mount  in  situ hybridization  experiments  for
rxfp3-1  transcript. Lateral  view  (A),  dorsal  view  of  embryo  at
pharyngula stage (B). Embryo at 48 hpf (C). Lateral view of embryo
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(D) and dorsal view of embryo at larval stage (E). Black arrowhead
indicates interrenal gland, red arrowhead indicates rhomboencephalon
nuclei,  Black  arrow  indicates  otic  vescicle.  OV:  otic  vescicle,  r:
rhomboencephalon, y: yolk.
 
Concerning  rxfp3-2a, we essentially found that the gene was mainly
expressed in the developing brain,  and, in addition, in the eyes and
thymus. At somitogenesis stage (16 hpf), the  rxfp3-2a transcript was
revealed in the diencephalic region, as evidenced by a lateral view of
the embryo (Figure. 20A). At the onset of pharyngula stage (24 hpf),
rxfp3-2a gene expression persisted in the diencephalon region and a
new transcript site was present in the ventral retina of the developing
eye  (Figure.  20B,  C)  and  in  the  rhombencephalic  region  (Figure.
20D). At late pharyngula stage (48 hpf), the expression of  rxfp3-2a
gene  was  revealed  in  the  ganglion  cell  layer  of  the  retina  (Figure.
20E). At this stage, the expression pattern showed a wide distribution
throughout  different  developing  brain  areas.  In  particular,  the
transcript was detected in the epiphysis,  diencephalon, optic tectum
and rhombencephalic  region  (Figure.  20F).  The transcript  was  also
evidenced  in  the  telencephalic  region  (Figure.  20F).  Moreover,  the
rxfp3-2a  expression  was  revealed  in  extraneural  territories,  in
particular, the hybridization signal marked bilateral cell groups in the
pharyngeal  arch  region  corresponding to  the thymus  (Figure.  20F).
We also  analysed  the rxfp3-2a  gene  expression  at  72  and  96  hpf,
essentially  revealing  similar  expression  pattern  at  both  stages.  In
particular, rxfp3-2a expression persisted in the ganglion cell layer and
in the thymus as well as in different cell clusters widely distributed in
the  brain  (Figure.  20G).  To  better  characterize  the  topographical
distribution of the  rxfp-2a transcript, we carried out serial transverse
sections of the hybridized zebrafish larvae. Sections led us to reveal
many cell clusters distributed in various regions of the larval brain,
and, in addition in the ganglion cell layer and thymus (Figure. 21). In
the forebrain, the expression of rxfp3-2a was evidenced in the pallium
(Figure. 21a). In addition, in the transverse section, the transcript was
also evident in a restricted cell cluster, which could represent either
the  telencephalic  migrated  area  or  the  migrated  entopeduncular
complex (Figure. 21a). A staining was revealed in the epyphisis and
44
Results
more laterally in a cell cluster located in the habenula (Figure. 21b).
Different positive cell clusters were also present in the thalamic region
and optic tectum, as evidenced by several transverse sections (Figure.
21b-k).  The  rxfp3-2a  transcript  were  revealed  in  migrated  pretectal
area  and  in  migrated  posterior  tuberculum  area  (Figure.  21C,  h).
Sections also revealed staining in cell groups which could represent,
nuclei of various cranial nerve, as oculomotor, trigeminal, abducens,
vagus  and  spinal  motor  nuclei  (Figure.  21k,  q-t).  Finally,  the
expression was  detected  in  cell  clusters  belonging  to  the region  of
nucleus  of  medial  longitudinal  fascicle,  superior  raphè,  and  in  cell
rows in the medulla oblongata (Figure. 21i, m-p, v-z). The analysis of
rxfp3-2b transcript at larval stages (72 and 96 hpf) makes not possible
the identification of specific signal, due to a faint hybridization signal
with  high  interfering  background  (data  not  shown).  This  was  in
agreement with the transcript level revealed by RT-PCR experiments,
which  showed  that  the  rxfp3-2b  transcript  was  undetectable
throughout the embryonic development and was revealed only starting
at larval stages at a very low level in comparison to rxfp3-2a.
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Figure.  20.  Whole  mount  in  situ hybridization  on  zebrafish
embryo for  rxfp3-2a transcript during embryogenesis. Embryo at
different developmental stage detected with  rxfp3-2a riboprobes (A-
G). Lateral  view of somitogenesis stage (A). Lateral (B) and dorsal
view (C) of early pharyngula stage. Lateral view of magnification of
rhomboencephalic region at early pharyngula stage (D). Magnification
of  zebrafish  eye  at  late  pharyngula  stage  (E).  Lateral  view of  flat
mounted brain region at pharyngula stage (F). Black arrow indicates e:
epiphysis and Th: thymus. lateral view of flat mounted brain region at
larva stage (G). Black arrow indicates e: epiphysis. D: diencephalon;
e:  epiphysis;  Hy:  hypothalamus;  OT:  optic  tectum;  R:
rhomboencephalon; T: telencephalon.
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Figure.  21.  Whole mount  in situ hybridization at 96 hpf lateral
view (α), dorsal view (β). Trasversal section of whole mount in situ
hybridization at 96 hpf zebrafish embryo. Red arrow indicates a cell
cluster likely representing M3 (entopeduncular migrated complex) or
M4 (telencephalic migrated area). Red arrowheads indicate row cells
in the medulla oblongata; CeP, cerebellar plate; DT, dorsal thalamus;
E,  ephiphysis;  Ha,  habenula;  Hc,  caudal  hypothalamus;  Hi,
intermediate  hypothalamus;  lfb,  lateral  forebrain  bundle;  IMR,
intermediate  raphè;  M1,  migrated  pretectal  area;  M2,  migrated
posterior  tuberculum  area;  M4,  telencephalic  migrated  area;  mlf,
medial longitudinal fascicle; MN, spinal motor neurons; MO, medulla
oblongata;  N, region of the nucleus of medial  longitudinal  fascicle;
NIII,  oculomotor  nerve  nucleus;  NV,  NVI,  NX,  nuclei  of  cranial
nerves; P, motor nuclei of pallium; Po, preoptic region; Pr, pretectum;
PT, posterior tuberculum; SCO, subcommissural organ; SR, superior
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raphè; T, midbrain tegmentum; TeO, optic tectum; Th, thymus; TVe,
telencephalic ventricle; Va, valvula cerebelli; VT, ventral thalamus.   
Regarding  to  rxfp3-3b,  from  fertilized  eggs  to  somitogenesis,  we
revealed faint  and broadly distributed hybridization signal  (data not
shown).  At early pharyngula stage (24 hpf), we observed a restricted
signal  in  ventral  retina  (Figure.  22A).  Lately,  at  48 hpf,  a  specific
signal was revealed in the mesencephalic region (Figure. 22B, C). At
early larval stage (72 hpf), the gene expression was observed in the
epiphysis  (Figure  22D)  and  in  some  scattered  cells  in  the
rhomboencephalon  (Figure.  22I).  Moreover,  at  larval  stage,  other
expression  territories  were  localized  in  the  raphè,  hypothalamus
(Figure.  22C,  E).  In  order  to  better  characterize   the  expression
territories,  we  performed  transverse  sections  of  the  hybridized
embryos  at  96  hpf  (Figure.  23A).  Sections  of  the  head  region
evidenced  the  expression  in  the  retinal  cells,  in  particular,  in  the
ganglion  cell  layer  (Figure.  23B).  In  the  brain  region,  particularly
evident is the expression in the ventral thalamus, optic tectum, M2,
(Figure  23B,  C)  and  more  caudally,  in  the  putative  periaqueductal
gray  (PAG),  the  putative  nucleus  incertus,  the  raphè  and
hyphothalamus (Figure. 23D, E, F.). In addiction, transverse sections
evidenced rxfp3-3b expression in the pancreas (Figure. 23I). 
48
Results
Figure.  22.  Whole  mount  in  situ hybridization  for  rxfp3-3b  at
different  developmental  stage  as  indicated  in  the  panel.  Lateral
view of embryo at early pharyngula stage (A). Dorsal lateral view of
embryo at late pharyngula stage (B). Embryo at early larval stage (C).
Magnification of epiphysis region of embryo at  early larval stage (D).
Ventral  view  of  embryo  at  early  larval  stage  (E).  Double  in  situ
hybridization for rln3a transcript (blue signal) and rxfp3-2b  transcript
(orange  signal)  dorsal  view  at  late  larval  stage  (F).  Black  arrow
indicates retina, black arrowhead indicates periacqueductal gray,  red
arrowhead indicates romboencephalic region. In the red rectangle is
indicated the nucleus incertus. e, epiphysis; Hc, caudal hypothalamus;
R, raphè.
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Figure. 23.  Whole mount  in situ hybridization at 96 hpf. Lateral
view (A), dorsal view for rxfp3-3b transcript (H) of embryo at 96 hpf.
The trasversal  section along the  embryo  at  96 hpf is  indicated  (A,
whole brain lateral view) and lateral view of 96 hpf zebrafish embryo
trunck region (H).  Blue arrowhead indicates nucleus incertus,  green
arrowhead  indicates  DT,  dorsal  thalamus;  H:  hypothalamus;  Hc,
caudal hypothalamus; M2, migrated posterior tuberculum area;  MO,
medulla  oblongata;  NI,  nucleus  incertus;  p,  pancreas;  PAG,
periaqueductal gray; po, preoptic area; R, raphè; T, tegmental nucleus;
TeO, optic tectum; VT, ventral thalamus.
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5.0 CONCLUSION
Relaxin ligand/receptor system has been widely studied in mammalian
adult  organisms.  This  molecular  system  is  involved  in  many
physiological functions ranging from reproduction to neuroendocrine
system. In  particular,  RLN has been mainly linked to reproduction,
although  many  studies  evidenced  its  involvement  in  other
physiological contexts since, among the expression and target tissues,
there are the brain, kidney, heart, liver, and pancreas. For INSL3 and
INSL5,  it  has  been  clearly  defined  their  roles  in  reproduction  and
gastrointestinal system respectively (Adham et al.,  1993, Conklin et
al., 1999). The most recently identified family member, the RLN3, has
been characterized as a neuropeptide involved in stress and metabolic
control  (Bathgate et  al.,  2002; 2013).  All the relaxin peptides exert
their  physiological  effects  by  interacting  and  activating  4  GPCR
receptors  [relaxin  family  peptide  receptors  1–4  (RXFP1–4)].  Few
studies  have  been  performed  on  the  relaxin/receptor  system during
embryonic development and in vertebrate models beyond mammals.
In  the  present  thesis,  I  reported,  the  identification,  cloning  and
characterization  of  relaxin  ligand/receptor  genes  in  the  zebrafish
experimental  model.  In  particular,  my  experimental  analysis  was
carried  out  during  embryonic  development.  Recent  evolutionary
analyses revealed that vertebrate RLN/INSL genes and their receptors
primarily diversified through the two rounds (2R) of whole genome
duplication (WGD), that occurred in early vertebrate evolution (Good
et al., 2012). In addition, the third whole teleost fish-specific WGD
(3R), further contributed to the current number of fish genes (Good et
al., 2012). As I reported in the introduction section, zebrafish genome
contains 6 relaxin ligand and 11 relaxin receptor genes (Figure. 2, 3).
Our  previous  results  already  highlighted  the  powerful  of  zebrafish
model for the relaxin ligand/receptor molecular characterization. The
rln3a/b gene expression pattern analysis showed both conserved and
divergent  features  compared  to  the  corresponding  mammalian
homologues. Taken overall, the experimental data supported the idea
of an ancestral  function of  Rln3  peptide as  a  neurotransmitter,  and
provided  the  first  evidence  of  the  existence  of  the  neural  territory
known as nucleus incertus (NI) in fish (Donizetti et al., 2008, 2009).
In order to extend the knowledge on relaxin system, in particular on
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its involvement in embryonic development, the present thesis focused
on the other zebrafish relaxin ligands and the cognate receptors. In the
present work, a preliminary analysis was performed to identify coding
region for two genes,  rln and rxfp1, which lacked in literature and in
public nucleotide databases.  Analysis  of the identified  rln sequence
showed  interesting  evolutionary  features.  Overall,  the  zebrafish
mature Rln amino acid sequence (made of B and A peptides) showed
higher similarity to the zebrafish Rln3a, Rln3b and human RLN3, than
to  the  homologue  mammalian  RLN.  This  reflects  the  common
evolutionary origin of that gene from a common ancestral RLN3-like
gene.  In  addition, the comparison highlighted that  during evolution
zebrafish  rln and  rln3 sequences  remained  more  similar than
mammalian  RLN  and  RLN3,  which  showed  greater  sequence
divergence (Hsu et al., 2003; Wilkinson et al., 2005; Wilkinson and
Bathgate 2007). In more detail, B and A domains of zebrafish relaxin
peptide evolved differently, in fact, B domain is more conserved than
A domain. Taking into account that the A domain might contribute to
ligand binding by orienting the B domain (Hossain et al., 2008; Park
et al., 2008), the dissimilarity of zebrafish Rln A domain could reflect
different binding specificity for the various relaxin receptors. My data
corroborates  the  idea  of  a  more  complex  ligand/receptor  pairing
scenario than previously imagined, in accordance with the data on the
ability of the mammalian RXFP3 to interact with H3, H2 and INSL3
ligands transducing different metabolic pathways (van der Westhuizen
et  al.,  2010).  For  what  concerns  the  rxfp1 gene,  the  general
conservation of syntenic genomic organization, exon-intron structure,
and of many amino acid residues important for ligand interaction and
receptor functioning supported the hypothesis of the identification of
the mammalian homologue of the zebrafish rxfp1.
The  analysis  of  expression  profile  of  relaxin  ligands  and receptors
genes was initially performed by PCR analysis. Results (summarized
in Table 3) showed that the relaxin/receptor system is active during
zebrafish  embryonic  development.  It  is  note  of  worth  that  some
receptor  genes  are  not  expressed  during embryogenesis,  suggesting
that  they  likely  are  required  later  in  organism's  life.  Another
interesting  insight  is  that,  when  duplicated,  the  paralogue  genes
showed  a  different  expression  pattern,  likely  reflecting  a
diversification of their function after their separation during evolution.
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Table  3.  Summary  of  relaxin  ligands  and receptors  embryonic
expression  pattern  analysed  by  RT-PCR  and  qRT-PCR
experiments. The  same  colour  indicates  the  paralogue  genes.  (the
rln3a and rln3b expression data are provided by Donizetti et al., 2008,
2009).
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Gene expression localization analysis was performed by means of in
situ  hybridization  experiments  and  summarized  in  Table  4.  Taken
overall, my data show that relaxin peptides and their cognate receptors
are  mainly  expressed  in  neuronal  territories.  These  data  further
corroborate the hypothesis of an ancestral neuroendocrine function for
the  relaxin  system.  In  addition,  several  non-neural  territories  are
shown to express relaxin ligand and receptor genes.
The zebrafish rln gene expression pattern, in part, reflects the common
evolutionary  origin  with  rln3a.  In  fact,  both  are  expressed  in  the
putative  zebrafish  nucleus  incertus,  as  a  consequence  of  common
inherited regulatory pathway.  Differently,  new expression territories
have  likely  been  acquired  in  rln expression  pattern  during
evolutionary diversification of relaxin genes. Among these territories,
the  olfactory  placode  cells  expressed  the  rln gene  throughout
embryogenesis. No expression in this territory was revealed in post-
embryonic larvae, leading to the hypothesis of a function for the Rln
in olfactory placode development. The rln gene expression was also
revealed in the preoptic area and around the anterior commissure of
the  telencephalon,  providing  evidence  of  an  involvement  in  the
development and functioning of the visual system. Moreover the  rln
gene expression was also detected in thyroid and pancreas  regions,
which  highlights  a  possible  role  as  a  paracrine  and  endocrine
hormone.  The  expression  pattern  of  zebrafish  rln revealed  that  in
comparison  to  rodents  there  are  some  expression  territories  in
common  between  fish  and  mammals,  both  in  the  brain  and  in
extraneural  territories such as  liver and pancreas   (Ma et  al.,  2006;
Halls et al., 2009; Burazin et al., 2005; Gunnersen et al., 1995).  The
insl-5a and  insl-5b paralogue genes are expressed in intestine tissue
during  embryonic  development.  I  demonstrated  that  in  the  adult
zebrafish,  these  two  genes  specialized  their  expression  pattern  in
different intestinal cell types. In particular, I revealed insl-5a transcript
in the goblet  cells,  whose function is to secrete mucus. Differently,
insl-5b  is  expressed  in  enteroendocrine  cells  (that  are  specialized
endocrine cells of the gastrointestinal tract),  which play critical roles
in regulating gastrointestinal secreting hormones. Taken into account
that in mouse and human, the INSL5 gene is expressed in the colon
and is likely involved in the intestinal motility (Conklin et al., 1999),
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my results show that this function has likely been established early in
vertebrate evolution.
In order to understand the role of relaxins during embryogenesis, my
analysis  included gene expression pattern of  their  receptors.  Rxfp1,
which in  mammals  is  the cognate  receptor  for  RLN, is  essentially
expressed in the neural territories. Among them, branchial arch region
and terminal  nerve,  which  share  a  common origin  from the neural
crests.  This might reflect  a function of  rxfp1 in the early phases of
development of such structures. The expression in the terminal nerve
involves all the embryonic stages, reflecting, more probably, a role for
the  rxfp1 receptor  in  the  neuromodulatory function  of  the  terminal
nerve.  I  found  gene  expression  in  the  epiphysis,  or  pineal  gland,
which,  in  non-mammalian  vertebrates  including  zebrafish,  contains
light-sensitive photoreceptor and all the elements required for photic
entrainment  and  circadian  rhythm  generation  (Vatine,  2011).  The
expression  of  the  rxfp1 gene  extends  in  other  territories  such  as
posterior  tuberculum,  preoptic  region,  optic  tectum,  involved  in
sensory process  of  the visual  system.  In  addition the  rxfp1  gene is
expressed  in  tegmentum⁄pons  region,  hindbrain  and  hypothalamus.
The expression of Rxfp1 receptor in all such neural territories suggests
a  role  in  different  neural  mechanisms  such  as  somatosensory
processing, neuroendocrine and autonomic regulation, as proposed for
the  homologue  receptor  in  the  adult  rat  brain  (Ma  et  al.,  2006).
Zebrafish  rxfp2-like gene (the mammalian homologue is considered
the  cognate  receptor  for  INSL3)  is  the  only  rxfp2 paralogue  gene
expressed  during  embryonic  development.  The  corresponding
transcript  is  localized in  the epiphysis,  habenula  and preoptic  area.
Also in rat brain there is high RXFP2 expression in the habenula and
other territories such as thalamic nuclei,  olfactory tubercle signalling
system,  which  are  involved  in  sensorimotor,  limbic  and  cognitive
functions (Sedaghat et al., 2008). 
Among relaxins receptors, teleost rxfp3s show the greatest expansion
in terms of orthologs and paralogs, since zebrafish genome possess 7
rxfp3 genes.  The  rxfp3-1 gene  is  expressed  in  the  developing
interrenal gland, the homologue of mammalian adrenocortical gland,
where  the  mammalian  RXFP3  gene  is  expressed.  The
interrenal/adrenal  gland  is  a  key  element  of  the  hypothalamic-
pituitary-adrenal/interrenal  axis that controls the stress response and
regulates  many  body  processes,  including  digestion,  the  immune
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system, mood and emotions, sexuality and energy storage (Chan et al.,
2008).  In  addition,  zebrafish  rxfp3-1  is  expressed  in  the
rhombencephalic region of larval brain. 
The  rxfp3-2a has  shown  the  most  complex  expression  pattern,  in
particular  in  the  developing  brain.  The  expression  territories  of
zebrafish  rxfp3-2a  relates  to  neural  structure  involved  in  visual
sensory perception and signal elaboration, leading to the idea of an
involvement  in  the  entire  visual-motor  system.  Another  interesting
feature of the rxfp3-2a gene is the expression in habenular cells. The
habenula is a neural structure involved in emotional behaviours which
conveys neural information from the limbic forebrain to the nuclei in
the ventral midbrain and hindbrain (such as raphè and nucleus incertus
in mammals and griseum centrale in fishes)  in a pathway which is
conserved  throughout  the  vertebrate  evolution  (Okamoto,  2012).
Moreover,  we observed the  rxfp3-2a expression in the pineal gland.
The  rxfp3-3b  gene  expression  pattern  also  offers  some  interesting
discussion items. In fact, zebrafish  rxfp3-3b shares with mammalian
RXFP3  the  expression  in  some  brain  areas.  Among  them,  the
periaqueductal gray, which is involved in pain analgesia, fear, anxiety,
vocalization (Olango et al., 2012; Sugiyama et al., 2010., Smith et al.,
2011);  in raphè,  which is  involved  in  the control  of  chronic  social
defeat  stress  (CSDS),  depression,  and  anxiety   (Boyarskikh  et  al.,
2013; Rozeske et al., 2011; Smith et al., 2011); in the hypothalamus,
which  is  involved  in  different  neural  processes,  among  them  the
control of sleep and social behaviour. In addition, among other neural
territories, I revealed the expression in the putative zebrafish nucleus
incertus,  which,  as  aforementioned  is  a  key  element  for  arousal
(sleep/wakefulness), stress reponses, and learning and memory; and is
involved  in  the  pathology  of  related  psychiatric  diseases  such  as
insomnia, anxiety and depression, and cognitive deficits (Ryan et al.,
2011). The  rxfp3-3b expression  was also revealed in the pancreatic
region.  Overall,  the  regions  where  we  detected  zebrafish  rxfp3
paralogue genes expression (both neural and non-neural) are mostly
overlapping with the mammalian homologue gene.  It has often been
argued that gene-duplication events are more commonly followed by
subfunctionalization  than  neofunctionalization  event  leading  to  the
duplicate-genes preservation. Indeed, the subfunctionalization process
may  facilitate  such  evolution  by  preserving  gene  duplicates  and
maintaining their  exposure  to natural  selection and/or  by removing
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pleiotropic  constraints  (Lynch  and Force.,  2000).  My data  seem in
agreement with such hypothesis where the subfunctionalization events
for the zebrafish rxfp3 genes in part recapitulated the expression, and
probably the function, of the mammalian RXFP3 and RXFP4 genes.  
In  conclusion, taken into account that  several  territories  of relaxins
and  receptors  gene  expression  are  shared  between  mammals  and
zebrafish, it is possible to hypothesize that also in fish they may have
many physiological effects involving olfactory system, vision system,
arousal  system,  circadian  rhythm,  fear,  learning,  memory,  feeding,
stress and metabolism. In addition, it is worth of note that, since that
genes  are expressed during embryonic  development,  their  functions
are established very early in the organism's life. 
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